N4 Pharma PLC (LON:N4P) CEO Nigel Theobald speaks to Proactive London's Andrew Scott following the release of the firm's interim results to June 2019.
He says it's been an incredibly active period for them where, among a number of developments, they've confirmed that Nuvec® works for both DNA and mRNA delivery.